Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets

Area of Science:

• Natural product chemistry
• Oncology
• Nanomedicine

Background:

• Cancer remains a leading cause of global mortality, with many patients experiencing relapse or resistance to current therapies.
• Developing novel anti-cancer agents is crucial due to poor tumor remission rates with existing treatments.
• Natural compounds are being investigated for their therapeutic potential against malignant cells.

Purpose of the Study:

• To review the scientific literature on the anti-neoplastic potential of emodin.
• To explore the safety and efficacy of emodin in targeting key cancer hallmarks.
• To discuss the application of nanotechnology platforms for emodin-based cancer therapy.

Main Methods:

• Literature review of preclinical and clinical studies on emodin.
• Analysis of emodin's mechanisms of action against cancer hallmarks.
• Evaluation of emodin's safety and toxicity profile.
• Assessment of nanotechnology-based delivery systems for emodin.

Main Results:

• Emodin demonstrates significant anti-cancer properties, including induction of apoptosis and cell cycle arrest.
• Emodin effectively targets tumor angiogenesis and metastasis.
• Emodin shows potential in overcoming chemoresistance in malignant cells.
• Emodin exhibits a favorable safety profile, particularly when explored with nanotechnology.

Conclusions:

• Emodin is a promising natural compound with broad anti-neoplastic activity.
• Nanotechnology platforms offer potential for sustained and effective delivery of emodin for cancer management.
• Emodin may serve as an effective therapeutic alternative or adjunct to conventional chemotherapy.